G
GenoPalate
GenoPalate analyzes genetic data, demographics and lifestyle information to deliver personalized insights for optimal healthy eating
About GenoPalate
GenoPalate, founded in 2016 by Dr. Sherry Zhang, a molecular biologist, is a company that specializes in personalized nutrition based on an individual's genetic makeup. Dr. Zhang's research in obesity and metabolism led her to the conclusion that a one-size-fits-all approach to dieting is ineffective, which sparked the idea for GenoPalate. The company has since raised $15.4 million in funding to support its growth and development.
GenoPalate's primary offering is an at-home DNA testing kit that analyzes a person's genetic information to provide personalized dietary recommendations. The process begins with the customer providing a saliva sample, which is then sent to GenoPalate's lab for analysis. The company's proprietary algorithm, developed by a team of scientists and dietitians, analyzes over 100 genetic markers known to influence how the body processes food and nutrients. Based on this analysis, GenoPalate generates a comprehensive report that includes personalized recommendations for macronutrients, vitamins, and minerals, as well as a list of over 85 foods that are most compatible with the individual's genetic profile. The company also offers personalized recipes and supplements to complement its dietary recommendations.
GenoPalate operates on a direct-to-consumer business model, selling its DNA testing kits and personalized nutrition plans directly to customers through its website. The company also partners with healthcare professionals and corporate wellness programs to offer its services to a wider audience. GenoPalate's target market includes individuals who are looking to optimize their health, manage their weight, or address specific health concerns through a personalized approach to nutrition.
Source: Dealroom company dataAt a glance
- Founded
- 2016
- Headquarters
- Wauwatosa, United States
- Sector
- Health Tech & Medtech
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
gener8tor
BrightStar Wisconsin Foundation
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about GenoPalate on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See GenoPalate on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.